• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • English
    Chinese
    French
    Japanese
    Korean
    German
    Spanish

    Renal Denervation Market Trends

    ID: MRFR/MED/5249-HCR
    115 Pages
    Kinjoll Dey
    September 2025

    Renal Denervation Market Research Report Information, By Product (Simplicity, Vessix (V2), EnligHTN, Paradise, Iberis, and Others), By Technology (Radiofrequency, Ultrasound, Micro-infusion, and Others), By End-User (Hospital, Clinics, Ambulatory Surgery Centers, and Others), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2032

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Renal Denervation Market Research Report - Forecast till 2032 Infographic
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0

    Market Trends

    Key Emerging Trends in the Renal Denervation Market

    Renal denervation, a medical procedure designed to treat hypertension by disrupting nerve signals to the kidneys, has witnessed significant market trends in recent years. The global market for renal denervation has been marked by a growing emphasis on innovative technologies, increasing prevalence of hypertension, and a surge in research and development activities. Among trends, the non – invasive treatment is one markedly, because both patient and doctors are after the non-surgical intervention. This has led to the appearance of catheter-based renal denervation methods with the reduced recovery time and the enhanced synergy between doctors and patients. Besides that, the market of the space tourism witnesses a clear tendency to create partnerships, collaborations and mergers. Medical device manufacturers and pharmaceutical companies have become more and more intertwined in respect of sharing experience, resources, as well as technical developments. This collaborative methodology would be aimed at fast-tracking development of the top tier renal denervation solutions and stimulation of the industry innovation, with the effect of improving the current market positioning. On that note, there is an appearance of a teamwork between research labs, health care providers, and industry stakeholders that are very useful to ensue comprehensive solutions as well as integrated approaches for hypertension management. Many people nowadays are starting to grasp the idea that a clear short path enables immediate action on hypertension, which is considered to be the leading risk factor to develop cardiovascular diseases unlike before. Renal denervation that achieves a lasting blood pressure reduction elicits considerable interest as an effective therapy in the regulatory of hypertension. Through educational program, awareness campaigns and the release of positive clinical outcomes, we have successful converted a complex situation to a more receptive market. Despite ongoing upbeat trends in the marketplace for Renal Denervation however, some impediments remain. While the clinical benefits of some of these procedures are clear, for instance in terms of reducing pain and improving physiological function, other challenges need to be addressed, such as the long-term clinical evidence, the standardization of procedural techniques, and the variability in the patient response. Overcoming these hurdles requires continued collaboration between stakeholders, ongoing research, and a commitment to refining and optimizing renal denervation technologies.

    Market Summary

    As per Market Research Future Analysis, the Global Renal Denervation Market was valued at USD 1.11 Billion in 2023 and is projected to reach USD 15.09 Billion by 2032, growing at a CAGR of 33.03% from 2024 to 2032. The market is driven by the rising prevalence of hypertension and the development of advanced renal denervation devices. Key players are focusing on R&D to enhance product offerings and expand their market presence.

    Key Market Trends & Highlights

    The renal denervation market is witnessing significant growth due to various factors.

    • Market Size in 2023: USD 1.11 Billion; Projected Market Size by 2032: USD 15.09 Billion.
    • CAGR from 2024 to 2032: 33.03%; driven by increasing cases of therapy-resistant hypertension.
    • North America is expected to dominate the market due to rising FDA approvals.
    • The radiofrequency technology segment holds the largest market share due to its safety and efficiency.

    Market Size & Forecast

    2023 Market Size USD 1.11 Billion
    2024 Market Size USD 1.53 Billion
    2032 Market Size USD 15.09 Billion
    CAGR (2024-2032) 33.03%
    Largest Regional Market North America.

    Major Players

    Key players include Boston Scientific, Medtronic, ReCor Medical, St. Jude Medical, Cardiosonic, Cordis, Kona Medical, Sound Intervention, and Terumo.

    Market Trends

    Rising cases of hypertension across people are driving the market growth

    The rise in the spread of chronic diseases and the growing spread of hypertension is driving Market CAGR for renal denervation. One of the key drivers of market growth is the increase in occurrences of therapy-resistant hypertension. One of the most prevalent diseases in the world is hypertension. More than 360,000 Americans died in 2013 as a result of high blood pressure, according to the Centers for Disease Control and Prevention (CDC). From 17,307 per 100,000 people in 1990 to 20,525 per 100,000 people in 2015, hypertension has increased. However, renal denervation therapy has successfully decreased blood pressure.

    The benefits of these therapies, such as their persistent effects, shorter treatment times, and improved safety levels, are thereby promoting market expansion. The development of renal denervation devices is also anticipated to fuel market growth.

    As an illustration, the development of catheter-based interventional therapy to ablate the renal nerve has demonstrated excellent benefits in the management of blood pressure in patients presenting with complaints of resistant hypertension. Additionally, the catheter-based approach facilitates the denervation of particular nerves and seems to be safer for patients.

    The amount of alcohol sold in 15 US states increased by 4% from January to August 2020 compared to a year earlier, as per the National Institute on Alcohol Abuse and Alcoholism. This could increase the risk of hypertension and encourage the use of renal denervation devices. Consequently, it is projected that the studied market would expand over the coming years as a result of factors such as an increase in product sales, the introduction of new products, and an increase in health problems connected to hypertension.

    Growth in the market is also predicted to be fueled by an increase in clinical studies, research, and development related to renal denervation devices, as well as the long-term advantages of renal denervation treatments. For instance, according to research that appeared in April 2022 issue of the journal Nature, more than 80% of Thai patients with resistant hypertension benefited from the effectiveness of renal nerve denervation, which was maintained over a longer follow-up period without any intervention-related side effects.

    It is also projected that the development of the healthcare infrastructure in emerging economies and the availability of substitutes and better technology, such as micro-infusion for renal denervation systems, will accelerate market expansion. For instance, the renal denervation system is based on micro-infusion from Mercator MedSystem. It distributes substances at a specified location to denervate the renal artery, lowering the patient’s blood pressure. Thus, driving the Renal Denervation Market revenue.

    The ongoing advancements in renal denervation techniques appear to enhance the therapeutic landscape for hypertension management, potentially leading to broader clinical adoption and improved patient outcomes.

    U.S. National Institutes of Health

    Renal Denervation Market Market Drivers

    Market Growth Projections

    The Global Renal Denervation Market Industry is poised for substantial growth, with projections indicating a market size of 1.53 USD Billion in 2024 and an anticipated increase to 35.5 USD Billion by 2035. This remarkable growth trajectory suggests a compound annual growth rate of 33.1% from 2025 to 2035, highlighting the increasing demand for renal denervation procedures. Factors such as rising hypertension prevalence, technological advancements, and a supportive regulatory environment are likely to drive this growth. The market's expansion reflects a broader trend towards innovative solutions in managing chronic health conditions.

    Increasing Healthcare Expenditure

    Increasing healthcare expenditure across various regions is positively impacting the Global Renal Denervation Market Industry. As governments and private sectors allocate more funds towards healthcare, there is a greater emphasis on innovative treatment options for chronic conditions such as hypertension. This trend is particularly evident in developed nations, where healthcare budgets are expanding to accommodate advanced medical technologies. The anticipated growth in healthcare spending is expected to facilitate the adoption of renal denervation procedures, contributing to the market's expansion and ensuring that patients have access to cutting-edge treatment options.

    Rising Prevalence of Hypertension

    The increasing prevalence of hypertension globally serves as a primary driver for the Global Renal Denervation Market Industry. As hypertension affects approximately 1.13 billion people worldwide, the demand for effective treatment options is escalating. Renal denervation, a minimally invasive procedure, has emerged as a promising alternative for patients who do not respond to traditional antihypertensive medications. The market is projected to reach 1.53 USD Billion in 2024, reflecting the urgent need for innovative solutions to manage hypertension effectively. This trend is likely to continue as healthcare providers seek to address the growing burden of hypertension-related complications.

    Supportive Regulatory Environment

    A supportive regulatory environment is fostering growth in the Global Renal Denervation Market Industry. Regulatory bodies are increasingly recognizing the potential of renal denervation as a treatment for hypertension, leading to expedited approvals for new devices and technologies. This regulatory support encourages manufacturers to invest in research and development, ultimately resulting in a wider array of treatment options for patients. As the market evolves, the favorable regulatory landscape is likely to enhance competition among manufacturers, driving innovation and improving patient access to renal denervation procedures.

    Technological Advancements in Medical Devices

    Technological advancements in medical devices are significantly influencing the Global Renal Denervation Market Industry. Innovations such as improved catheter designs, enhanced imaging techniques, and robotic-assisted procedures are enhancing the efficacy and safety of renal denervation. These advancements not only improve patient outcomes but also increase the adoption rate among healthcare professionals. As a result, the market is expected to experience robust growth, with projections indicating a rise to 35.5 USD Billion by 2035. Such developments suggest that the integration of cutting-edge technology into renal denervation procedures could potentially revolutionize treatment paradigms.

    Growing Awareness and Acceptance of Renal Denervation

    Growing awareness and acceptance of renal denervation among both healthcare providers and patients are driving the Global Renal Denervation Market Industry. Educational initiatives and clinical trial results have contributed to a better understanding of the procedure's benefits, leading to increased patient referrals. As more patients become aware of renal denervation as a viable treatment option for resistant hypertension, the demand is likely to surge. This trend is expected to be reflected in the market's growth trajectory, with a compound annual growth rate of 33.1% projected from 2025 to 2035, indicating a shift towards more innovative hypertension management strategies.

    Market Segment Insights

    Renal Denervation Product Insights

    The Market segments of Renal Denervation, based on product includes Simplicity, Vessix (V2), EnligHTN, Paradise, Iberis, and Others. The biggest market share for renal denervation was simplicity. Due to its delivery of low-level radiofrequency energy and consequent reduction in the risk of radiation exposure to body tissues from high-level radiofrequency, this system is most frequently employed to treat hypertension. Additionally, it provides a minimally intrusive method for treating severe hypertension.

    Renal Denervation Technology Insights

    The Renal Denervation Market segmentation, based on technology, includes Radiofrequency, Ultrasound, Micro-infusion, and Others. Due to its benefits, including safety and time efficiency, the radiofrequency category had the biggest market share. As ultrasound devices get around the restrictions of radiofrequency-based systems, the segment is expected to grow at the highest CAGR. The nerves are destroyed by ultrasound energy using high-frequency sound waves without making direct contact with the tissues, which lessens damage to the renal arteries.

    Renal Denervation End-User Insights

    The Market segmentation of Renal Denervation, based on end-user, includes hospitals, Clinics, Ambulatory surgery centers, and Others. Due to the rising demand for renal denervation, the hospitals segment dominates the end-user section of the worldwide renal denervation market.

    Figure 1: Renal Denervation Market, by End-User, 2022 & 2032 (USD Billion) 

    Source: Secondary Research, Primary Research, Market Research Future Database, and Analyst Review

    Get more detailed insights about Renal Denervation Market Research Report - Forecast till 2032

    Regional Insights

    By region, the study provides market insights into North America, Europe, Asia-Pacific, and the Rest of the World. Due to the increasing number of requests for FDA approvals in the U.S., North America is expected to dominate the market. As an illustration, the FDA has permitted Medtronic to begin a key Investigational Device Exemption (IDE) trial to test the Symplicity Spyral renal denervation system in patients with hypertension.

    Further, the major countries studied in the market report are The US, Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

    Figure 2: RENAL DENERVATION MARKET SHARE BY REGION 2022 (USD Billion) 

    RENAL DENERVATION MARKET SHARE BY REGION 2022

    Source: Secondary Research, Primary Research, Market Research Future Database, and Analyst Review

    Europe’s Renal Denervation Market accounts for the second-largest position in the market. This is a result of increased R&D efforts for the creation of effective devices. The prevalence of drug-resistant hypertension will also rise, fueling the area's expansion. Further, the UK market of Renal Denervation held the largest market share, and the Germany market of Renal Denervation was the quickest-growing market in the North American region

    The Asia-Pacific Renal Denervation Market is anticipated to expand at the quickest CAGR. This is due to the abundance of unmet medical needs for the treatment of hypertension, growing knowledge of the utilization of cutting-edge technology such as renal denervation systems, and the high prevalence of resistant hypertension. Moreover, China market of Renal Denervation held the fastest CAGR, and the India market of Renal Denervation was the quickest-growing market in the Asia-Pacific region.

    Key Players and Competitive Insights

    Leading market players are investing largely in research & development-related activities to extend their product/service lines, which will aid the market of Renal Denervation, to grow faster. Market leaders are also adopting a range of strategies to expand their worldwide position, with important market developments including new product launches & developments, contractual agreements among companies with complementary service lines, mergers & acquisitions, increased investments, & collaboration with other organizations having complementary products and services. To grow in a competitive and rising market climate, the Renal Denervation industry needs to offer cost-efficient products.

    Producing locally to cut operational expenses is one of the prime business strategies used by manufacturers in the Renal Denervation industry to benefit clients and increase the market sector. In recent years, the Renal Denervation industry has served with some of the key perks of medicine. Major players in the Renal Denervation Market, including Boston Scientific, Medtronic, ReCor Medical, St. Jude Medical, Cardiotonic, Cordis, Kona Medical, Sound Intervention, Terumo, and others are attempting to increase market growth via investing in research and development operations.

    ReCor Medical is a manufacturer of medical equipment and a leader in the development of Ultrasound Renal Denervation (ADN) technology for the management of hypertension, one of the most common medical disorders. ReCor Medical creates and produces the Paradise Ultrasound Renal Denervation system, which uses ultrasound energy to treat overactive renal nerves during a single minimally invasive operation to control high blood pressure. Only exploratory use of the Paradise System is permitted within the United States. only for distribution in nations with CE certification. ReCor Medical Inc. is the owner of the trademark The Paradise System.

    In February 2023, According to a study, the Paradise ultrasonic renal denervation (uRDN) device from ReCor Medical successfully lowered blood pressure. The Radiance clinical trial findings are significant because they confirm the Paradise uRDN System's usefulness as a supplementary therapy for the treatment of hypertension.

    Designing, developing, producing, and marketing medical devices and solutions are the core competencies of Medtronic Plc (Medtronic), formerly known as Medtronic Inc. It provides goods for the treatment of conditions such as diseases of the heart valves, heart failure, peripheral vascular, venous renal, and neurological diseases, spine and musculoskeletal disorders, and ear, nose, and throat conditions. It also provides goods for the treatment of aortic, coronary, peripheral, and peripheral vascular diseases. For the dentistry and orthopedic businesses, it also offers biologic solutions.

    In the regions of Asia Pacific, Europe, the Americas, the Middle East, and Africa, it offers its products to hospitals, third-party healthcare providers, clinics, institutions, and government healthcare programs. Dublin, Ireland serves as the company's headquarters. In September 2022, According to trial results released by Medtronic, the Symplicity renal denervation device significantly lowers blood pressure. The radiofrequency renal denervation (RF RDN) procedure was performed on individuals in the SYMPLICITY HTN-3 clinical trial using first-generation Symplicity. Results showed that when compared to a sham control group, office, and ambulatory blood pressure decreased statistically significantly.

    Key Companies in the Renal Denervation Market market include

    Industry Developments

    July 2023:The new European Hypertension Society (ESH) recommendations, which emphasize the importance of renal denervation (RDN) as a component of the hypertension therapy pathway, are very exciting to Medtronic. The recommendations were released concurrently in the Journal of Hypertension and during the ESH 32nd Annual Meeting.

    Future Outlook

    Renal Denervation Market Future Outlook

    The Global Renal Denervation Market is projected to grow at a 33.1% CAGR from 2024 to 2035, driven by technological advancements, increasing hypertension prevalence, and rising awareness of renal denervation benefits.

    New opportunities lie in:

    • Develop innovative catheter-based systems for enhanced patient outcomes.
    • Expand into emerging markets with tailored renal denervation solutions.
    • Leverage telemedicine for remote patient monitoring and follow-up care.

    By 2035, the Renal Denervation Market is expected to be a robust sector, reflecting substantial growth and innovation.

    Market Segmentation

    Renal Denervation Regional Outlook

    • US
    • Canada

    Renal Denervation, Product Outlook (USD Billion, 2018-2032)

    • Simplicity
    • Vessix (V2)
    • EnligHTN
    • Paradise
    • Iberis
    • Others

    Renal Denervation, End-users Outlook (USD Billion, 2018-2032)

    • Hospital
    • Clinics
    • Ambulatory surgery centers
    • Others

    Renal Denervation, Technology Outlook (USD Billion, 2018-2032)

    • Radiofrequency
    • Ultrasound
    • Micro-infusion
    • Others

    Report Scope

    Report Attribute/Metric Details
    Market Size 2023 USD 1.11 Billion
    Market Size 2024 USD 1.53 Billion
    Market Size 2032 USD 15.09 Billion
    Compound Annual Growth Rate (CAGR) 33.03% (2024-2032)
    Base Year 2023
    Market Forecast Period 2024-2032
    Historical Data 2018- 2022
    Market Forecast Units Value (USD Billion)
    Report Coverage Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends
    Segments Covered Product, Technology, End-User, and Region
    Geographies Covered North America, Europe, Asia Pacific, and the Rest of the World
    Countries Covered The US, Canada, German, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil
    Key Companies Profiled Boston Scientific, Medtronic, ReCor Medical, St. Jude Medical, Cardiotonic, Cordis, Kona Medical, Sound Intervention, and Terumo
    Key Market Opportunities Rising research & development activities across healthcare
    Key Market Dynamics Increasing cases of hypertension among individuals

    Market Highlights

    Author

    Kinjoll Dey
    Research Analyst Level I

    She holds an experience of about 6+ years in market research and business consulting, working under the spectrum of information communication technology, telecommunications and semiconductor domains. aarti conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. her expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.

    Leave a Comment

    Latest Comments

    John Doe

    This is a great article! Really helped me understand the topic better.

    Posted on July 23, 2025, 10:15 AM
    Jane Smith

    Thanks for sharing this. I’ve bookmarked it for later reference.

    Posted on July 22, 2025, 7:45 PM

    FAQs

    How Much is the Renal Denervation Market?

    The Renal Denervation Market size was valued at USD 1.11 Billion in 2023.

    What is the growth rate of the Renal Denervation Market?

    The market is projected to grow at a CAGR of 33.03% during the forecast period, 2024-2032.

    Which region held the largest market share in the Renal Denervation Market?

    North America had the largest share of the market

    Who are the key players in the Renal Denervation Market?

    The key players in the market are Boston Scientific, Medtronic, ReCor Medical, St. Jude Medical, Cardiotonic, Cordis, Kona Medical, Sound Intervention, and Terumo.

    Which technology segment led the Renal Denervation Market?

    The radiofrequency category dominated the market in 2023.

    Which product had the largest market share in the Renal Denervation Market?

    Simplicity had the largest share of the market.

    1. 'Table of Contents:      Chapter 1.    Report Prologue    
    2. Chapter 2.    Market Introduction    
      1.     Definition    
      2.     Scope of the Study    
        1.     Research Objective    
        2.     Assumptions    
        3.     Limitations     Chapter
      3.     Introduction
      4.     Primary Research    
      5.     Secondary Research    
      6.     Market Size Estimation Chapter
      7.     Drivers    
      8.     Restraints
      9.     Opportunities    
      10.     Challenges
      11.     Macroeconomic Indicators
      12.     Technology Trends & Assessment Chapter 5.    Market Factor Analysis
      13.     Porter’s Five Forces Analysis
        1.     Bargaining
    3. Power of Suppliers    
      1.     Bargaining Power of Buyers
        1.     Threat
    4. of New Entrants    
      1.     Threat of Substitutes    
        1.   
    5.  Intensity of Rivalry    
      1.     Value Chain Analysis
      2.     Investment Feasibility Analysis    
      3.     Pricing Analysis Chapter 6.    Global
    6. Renal Denervation Market, by Product
      1.     Introduction
      2.     Symplicity Market Estimates
    7. Forecast by region, 2020-2027
    8.            Market Estimates & Forecast country, 2020-2027
      1.     Vessix (V2)  
    9.           Market Estimates & Forecast by region, 2020-2027      
    10.        Market Estimates & Forecast country, 2020-2027
      1.     EnligHTN      
    11.       Market Estimates & Forecast by region, 2020-2027      
    12.        Market Estimates & Forecast country, 2020-2027
      1.     Paradise      
    13.       Market Estimates & Forecast by region, 2020-2027      
    14.        Market Estimates & Forecast country, 2020-2027
      1.     Iberis      
    15.       Market Estimates & Forecast by region, 2020-2027      
    16.        Market Estimates & Forecast country, 2020-2027      
    17.        Market Estimates & Forecast country, 2020-2027 Chapter 7.  
    18.  Global Renal Denervation Market, By Technology
      1.     Introduction
      2.     Radiofrequency Market Estimates
    19. Forecast by region, 2020-2027
    20.               Market Estimates
    21. & Forecast country, 2020-2027
      1.     Ultrasound 
    22. Market Estimates & Forecast by region, 2020-2027      
    23.      Market Estimates & Forecast country, 2020-2027
      1.     Micro-infusion  Market Estimates
    24. Forecast by region, 2020-2027
    25.            Market Estimates & Forecast country, 2020-2027       
    26. Chapter 8.    Global Renal Denervation Market, by End-user Type
      1.     Introduction
      2.     Food Producing Animals 
    27. Market Estimates & Forecast by region, 2020-2027      
    28.      Market Estimates & Forecast country, 2020-2027
      1.     Companion Animals  Market
    29. Estimates & Forecast by region, 2020-2027
    30.            Market Estimates
    31. & Forecast country, 2020-2027
    32. Chapter 9.    Global Renal Denervation Market, by Region
      1.     Introduction
      2.     Americas
        1.     North America
        2.     South America
      3.     Europe
        1.     Western Europe
    33.  Rest of Western Europe
      1.     Eastern Europe
      2.     Asia Pacific
        1.     Japan
        2.     China
        3.     India
        4.     Australia
        5.     Republic of Korea
        6.   
    34.  Rest of Asia Pacific
      1.     The Middle East & Africa
        1.     The Middle East
        2.      Africa Chapter
      2.     Introduction    
      3.     Market Share Analysis    
      4.     Key Development & Strategies     Chapter
      5.     Boston Scientific
        1.     Company Overview    
        2.     Product Overview    
        3.     Financials Overview
        4.     Key Developments    
        5.     SWOT Analysis    
      6.     Medtronic 
        1.     Company Overview    
        2.     Product Overview    
        3.     Financial Overview    
        4.     Key Developments    
        5.     SWOT Analysis    
      7.     ReCor Medical
        1.     Company Overview    
        2.     Product Overview    
        3.     Financial Overview
        4.     Key Development    
        5.     SWOT Analysis    
      8.     St. Jude Medical 
        1.     Company Overview    
        2.     Business Segment Overview    
        3.     Financial Overview    
        4.     Key Development    
        5.     SWOT Analysis    
      9.      Cardiosonic
        1.     Company Overview    
        2.     Product Overview    
        3.     Financial overview    
        4.     Key Developments
        5.   
    35.  SWOT Analysis        
      1.      Cordis
        1.     Company Overview    
        2.     Product Overview    
        3.     Financial Overview    
        4.     Key Developments
        5.     SWOT Analysis        
      2.     Merial
        1.     Overview    
        2.     Product Overview    
        3.     Financial Overview    
        4.     Key Developments    
        5.     SWOT Analysis    
      3.     Kona Medical
        1.     Overview    
        2.     Product Overview    
        3.     Financial Overview    
        4.     Key Developments    
        5.     SWOT Analysis    
      4.     Sound Intervention
        1.     Overview    
        2.     Product Overview    
        3.     Financial Overview    
        4.     Key Developments    
        5.     SWOT Analysis    
      5.     Terumo Corporation
        1.     Overview    
        2.     Product Overview    
        3.     Financial Overview    
        4.     Key Developments    
        5.     SWOT Analysis    
      6.    Others
    36. Chapter 12    MRFR Conclusion     
      1.     Key Findings    
        1.     From CEO’s View Point    
        2.     Unmet
    37. Needs of the Market    
      1.     Key Companies to Watch    
      2.   
    38.  Prediction of the Renal Denervation Industry Chapter 13    Appendix
    39.      Global Renal Denervation Market Synopsis, 2020-2027
    40.  Global Renal Denervation Market Estimates and Forecast, 2020-2027, (USD  Million)
    41.                        
    42.                           
    43. 3        Global Renal Denervation Market, by Region
    44. 2020-2027, (USD Million)                
    45.          
    46. Denervation Market, by Product, 2020-2027, (USD Million)
    47. Renal Denervation Market, By Technology, 2020-2027, (USD Million)    
    48.                        
    49.                        
    50.                        
    51.                               
    52. Market, by End-user type, 2020-2027, (USD Million)          
    53.                
    54. Denervation Market, by Product, 2020-2027, (USD Million)        
    55.                 
    56. America Global Renal Denervation Market, by End-user type, 2020-2027,       
    57.                    (USD  
    58. Million)                      
    59.                              
    60. 2020-2027,   
    61.                        
    62. (USD    Million)                
    63.                        
    64.                        
    65.                        
    66.          
    67. by Product, 2020-2027, (USD Million)              
    68.           
    69. by End-user type, 2020-2027, (USD Million)
    70. By Technology, 2020-2027, (USD Million)            
    71.                        
    72.              
    73. Market,by Product, 2020-2027, (USD Million)
    74. Market,by End-user type, 2020-2027, (USD Million)          
    75.                        
    76.                
    77. Market, By Technology, 2020-2027, (USD Million)          
    78.                        
    79.                  
    80. America Renal Denervation Market, by Product, 2020-2027, (USD 
    81.          
    82.                 Million)
    83. America Renal Denervation Market, by End-user type, 2020-2027, (USD       
    84.                    Million)  
    85.                        
    86.                     
    87.  South America Renal Denervation Market, By Technology, 2020-2027, (USD       
    88.                     Million)  
    89.                        
    90.                        
    91.  Europe Renal Denervation Market, by Product, 2020-2027, (USD Million)
    92.  Europe Renal Denervation Market, by End-user type, 2020-2027, (USD Million)
    93.                        
    94.                              
    95. 21    Europe Renal Denervation Market, By Technology, 2020-2027
    96. (USD Million)                    
    97.                        
    98.        
    99. by Product, 2020-2027, (USD 
    100.                    
    101.       Million)
    102. by End-user type, 2020-2027, 
    103.                
    104.           (USD Million)          
    105.                        
    106.                
    107. Market, By Technology, 2020-2027, (USD 
    108.              
    109.             Million)          
    110.                        
    111.                        
    112.                  
    113. Europe Renal Denervation Market, by Product, 2020-2027, (USD 
    114.          
    115.                 Million)
    116. Europe Renal Denervation Market, by End-user type, 2020-2027, (USD       
    117.                    Million)  
    118.                       
    119.  Eastern Europe Renal Denervation Market, By Technology, 2020-2027, (USD        
    120.                     Million)  
    121.                        
    122.                          
    123. 28    Asia Pacific Renal Denervation Market, by Product, 2020-2027, (USD     
    124.                        Million)
    125.  Asia Pacific Renal Denervation Market, by End-user type, 2020-2027, (USD         
    126.                    Million)  
    127.                        
    128.                        
    129.                   
    130. Pacific Renal Denervation Market, By Technology, 2020-2027, (USD       
    131.                    Million)  
    132.                       
    133.  Middle East & Africa Renal Denervation Market, by Product, 2020-2027, (USD   
    134.                         Million)
    135. 32    Middle East & Africa Renal Denervation Market, by End-user type, 2020-2027,   
    136.                        (USD
    137. Million)                      
    138.                              
    139. 33    Middle East & Africa Renal Denervation Market, By Technology
    140. 2020-2027,   
    141.                        
    142. (USD Million)                           LIST OF FIGURES 1    Research Process Denervation Market
    143. 3    Segmentation Market Dynamics for Global Renal Denervation Market
    144.                          
    145. 4    Global Renal Denervation Market Share, by Product 2020
    146.  Global Renal Denervation Market Share, by End-user type 2020
    147. Renal Denervation Market Share, By Technology, 2020
    148. Market Share, by Region, 2020 by Country, 2020
    149. 9    Europe Renal Denervation Market Share, by Country, 2020
    150. Asia Pacific Renal Denervation Market Share, by Country, 2020
    151. East & Africa Renal Denervation Market Share, by Country, 2020    
    152.                       
    153.  Global Renal Denervation Market: Company Share Analysis, 2020 (%)    
    154.                       
    155.  Boston Scientific: Key Financials Revenue
    156.  ReCor Medical: Geographical Revenue Financials
    157. 23    St. Jude Medical: Segmental Revenue Revenue
    158. 25     Cardiosonic:Key Financials Revenue
    159. 27     Cardiosonic. Geographical Revenue
    160.   Lonza: Segmental Revenue Key Financials
    161. 32    Merial: Segmental Revenue Revenue
    162. 35    Kona Medical: Segmental Revenue Revenue
    163. 37    Kona Medical: Key Financials Revenue
    164. 39    Sound Intervention: Geographical Revenue Intervention: Key Financials
    165.  Terumo Corporation: Geographical Revenue Financials'

    Market Segmentation

    Renal Denervation, Product Outlook (USD Billion, 2018-2032)

    • Simplicity
    • Vessix (V2)
    • EnligHTN
    • Paradise
    • Iberis
    • Others

    Renal Denervation, Technology Outlook (USD Billion, 2018-2032)

    • Radiofrequency
    • Ultrasound
    • Micro-infusion
    • Others

    Renal Denervation, End-users Outlook (USD Billion, 2018-2032)

    • Hospital
    • Clinics
    • Ambulatory surgery centers
    • Others

    Renal Denervation Regional Outlook (USD Billion, 2018-2032)

    • North America Outlook (USD Billion, 2018-2032)

      • North America Renal Denervation by Product
        • Simplicity
        • Vessix (V2)
        • EnligHTN
        • Paradise
        • Iberis
        • Others
      • North America Renal Denervation by Technology
        • Radiofrequency
        • Ultrasound
        • Micro-infusion
        • Others
      • North America Renal Denervation by End-users
        • Hospital
        • Clinics
        • Ambulatory surgery centers
        • Others
      • US Outlook (USD Billion, 2018-2032)

      • US Renal Denervation by Product
        • Simplicity
        • Vessix (V2)
        • EnligHTN
        • Paradise
        • Iberis
        • Others
      • US Renal Denervation by Technology
        • Radiofrequency
        • Ultrasound
        • Micro-infusion
        • Others
      • US Renal Denervation by End-users
        • Hospital
        • Clinics
        • Ambulatory surgery centers
        • Others
      • CANADA Outlook (USD Billion, 2018-2032)

      • CANADA Renal Denervation by Product
        • Simplicity
        • Vessix (V2)
        • EnligHTN
        • Paradise
        • Iberis
        • Others
      • CANADA Renal Denervation by Technology
        • Radiofrequency
        • Ultrasound
        • Micro-infusion
        • Others
      • CANADA Renal Denervation by End-users
        • Hospital
        • Clinics
        • Ambulatory surgery centers
        • Others
    • Europe Outlook (USD Billion, 2018-2032)

      • Europe Renal Denervation by Product
        • Simplicity
        • Vessix (V2)
        • EnligHTN
        • Paradise
        • Iberis
        • Others
      • Europe Renal Denervation by Technology
        • Radiofrequency
        • Ultrasound
        • Micro-infusion
        • Others
      • Europe Renal Denervation by End-users
        • Hospital
        • Clinics
        • Ambulatory surgery centers
        • Others
      • Germany Outlook (USD Billion, 2018-2032)

      • Germany Renal Denervation by Product
        • Simplicity
        • Vessix (V2)
        • EnligHTN
        • Paradise
        • Iberis
        • Others
      • Germany Renal Denervation by Technology
        • Radiofrequency
        • Ultrasound
        • Micro-infusion
        • Others
      • Germany Renal Denervation by End-users
        • Hospital
        • Clinics
        • Ambulatory surgery centers
        • Others
      • France Outlook (USD Billion, 2018-2032)

      • France Renal Denervation by Product
        • Simplicity
        • Vessix (V2)
        • EnligHTN
        • Paradise
        • Iberis
        • Others
      • France Renal Denervation by Technology
        • Radiofrequency
        • Ultrasound
        • Micro-infusion
        • Others
      • France Renal Denervation by End-users
        • Hospital
        • Clinics
        • Ambulatory surgery centers
        • Others
      • UK Outlook (USD Billion, 2018-2032)

      • UK Renal Denervation by Product
        • Simplicity
        • Vessix (V2)
        • EnligHTN
        • Paradise
        • Iberis
        • Others
      • UK Renal Denervation by Technology
        • Radiofrequency
        • Ultrasound
        • Micro-infusion
        • Others
      • UK Renal Denervation by End-users
        • Hospital
        • Clinics
        • Ambulatory surgery centers
        • Others
      • ITALY Outlook (USD Billion, 2018-2032)

      • ITALY Renal Denervation by Product
        • Simplicity
        • Vessix (V2)
        • EnligHTN
        • Paradise
        • Iberis
        • Others
      • ITALY Renal Denervation by Technology
        • Radiofrequency
        • Ultrasound
        • Micro-infusion
        • Others
      • ITALY Renal Denervation by End-users
        • Hospital
        • Clinics
        • Ambulatory surgery centers
        • Others
      • SPAIN Outlook (USD Billion, 2018-2032)

      • Spain Renal Denervation by Product
        • Simplicity
        • Vessix (V2)
        • EnligHTN
        • Paradise
        • Iberis
        • Others
      • Spain Renal Denervation by Technology
        • Radiofrequency
        • Ultrasound
        • Micro-infusion
        • Others
      • Spain Renal Denervation by End-users
        • Hospital
        • Clinics
        • Ambulatory surgery centers
        • Others
      • Rest Of Europe Outlook (USD Billion, 2018-2032)

      • Rest Of Europe Renal Denervation by Product
        • Simplicity
        • Vessix (V2)
        • EnligHTN
        • Paradise
        • Iberis
        • Others
      • REST OF EUROPE Renal Denervation by Technology
        • Radiofrequency
        • Ultrasound
        • Micro-infusion
        • Others
      • REST OF EUROPE Renal Denervation by End-users
        • Hospital
        • Clinics
        • Ambulatory surgery centers
        • Others
    • Asia-Pacific Outlook (USD Billion, 2018-2032)

      • Asia-Pacific Renal Denervation by Product
        • Simplicity
        • Vessix (V2)
        • EnligHTN
        • Paradise
        • Iberis
        • Others
      • Asia-Pacific Renal Denervation by Technology
        • Radiofrequency
        • Ultrasound
        • Micro-infusion
        • Others
      • Asia-Pacific Renal Denervation by End-users
        • Hospital
        • Clinics
        • Ambulatory surgery centers
        • Others
      • China Outlook (USD Billion, 2018-2032)

      • China Renal Denervation by Product
        • Simplicity
        • Vessix (V2)
        • EnligHTN
        • Paradise
        • Iberis
        • Others
      • China Renal Denervation by Technology
        • Radiofrequency
        • Ultrasound
        • Micro-infusion
        • Others
      • China Renal Denervation by End-users
        • Hospital
        • Clinics
        • Ambulatory surgery centers
        • Others
      • Japan Outlook (USD Billion, 2018-2032)

      • Japan Renal Denervation by Product
        • Simplicity
        • Vessix (V2)
        • EnligHTN
        • Paradise
        • Iberis
        • Others
      • Japan Renal Denervation by Technology
        • Radiofrequency
        • Ultrasound
        • Micro-infusion
        • Others
      • Japan Renal Denervation by End-users
        • Hospital
        • Clinics
        • Ambulatory surgery centers
        • Others
      • India Outlook (USD Billion, 2018-2032)

      • India Renal Denervation by Product
        • Simplicity
        • Vessix (V2)
        • EnligHTN
        • Paradise
        • Iberis
        • Others
      • India Renal Denervation by Technology
        • Radiofrequency
        • Ultrasound
        • Micro-infusion
        • Others
      • India Renal Denervation by End-users
        • Hospital
        • Clinics
        • Ambulatory surgery centers
        • Others
      • Australia Outlook (USD Billion, 2018-2032)

      • Australia Renal Denervation by Product
        • Simplicity
        • Vessix (V2)
        • EnligHTN
        • Paradise
        • Iberis
        • Others
      • Australia Renal Denervation by Technology
        • Radiofrequency
        • Ultrasound
        • Micro-infusion
        • Others
      • Australia Renal Denervation by End-users
        • Hospital
        • Clinics
        • Ambulatory surgery centers
        • Others
      • Rest of Asia-Pacific Outlook (USD Billion, 2018-2032)

      • Rest of Asia-Pacific Renal Denervation by Product
        • Simplicity
        • Vessix (V2)
        • EnligHTN
        • Paradise
        • Iberis
        • Others
      • Rest of Asia-Pacific Renal Denervation by Technology
        • Radiofrequency
        • Ultrasound
        • Micro-infusion
        • Others
      • Rest of Asia-Pacific Renal Denervation by End-users
        • Hospital
        • Clinics
        • Ambulatory surgery centers
        • Others
    • Rest of the World Outlook (USD Billion, 2018-2032)

      • Rest of the World Renal Denervation by Product
        • Simplicity
        • Vessix (V2)
        • EnligHTN
        • Paradise
        • Iberis
        • Others
      • Rest of the World Renal Denervation by Technology
        • Radiofrequency
        • Ultrasound
        • Micro-infusion
        • Others
      • Rest of the World Renal Denervation by End-users
        • Hospital
        • Clinics
        • Ambulatory surgery centers
        • Others
      • Middle East Outlook (USD Billion, 2018-2032)

      • Middle East Renal Denervation by Product
        • Simplicity
        • Vessix (V2)
        • EnligHTN
        • Paradise
        • Iberis
        • Others
      • Middle East Renal Denervation by Technology
        • Radiofrequency
        • Ultrasound
        • Micro-infusion
        • Others
      • Middle East Renal Denervation by End-users
        • Hospital
        • Clinics
        • Ambulatory surgery centers
        • Others
      • Africa Outlook (USD Billion, 2018-2032)

      • Africa Renal Denervation by Product
        • Simplicity
        • Vessix (V2)
        • EnligHTN
        • Paradise
        • Iberis
        • Others
      • Africa Renal Denervation by Technology
        • Radiofrequency
        • Ultrasound
        • Micro-infusion
        • Others
      • Africa Renal Denervation by End-users
        • Hospital
        • Clinics
        • Ambulatory surgery centers
        • Others
      • Latin America Outlook (USD Billion, 2018-2032)

      • Latin America Renal Denervation by Product
        • Simplicity
        • Vessix (V2)
        • EnligHTN
        • Paradise
        • Iberis
        • Others
      • Latin America Renal Denervation by Technology
        • Radiofrequency
        • Ultrasound
        • Micro-infusion
        • Others
      • Latin America Renal Denervation by End-users
        • Hospital
        • Clinics
        • Ambulatory surgery centers
        • Others
    Infographic

    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Get Free Sample

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne

    Founder
    Case Study

    Smartphone Motherboard Parts Manufacturing Research